BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nagata LP, Irwin CR, Hu WG, Evans DH. Vaccinia-based vaccines to biothreat and emerging viruses. Biotechnol Genet Eng Rev 2018;34:107-21. [PMID: 29779454 DOI: 10.1080/02648725.2018.1471643] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hazlewood JE, Dumenil T, Le TT, Slonchak A, Kazakoff SH, Patch AM, Gray LA, Howley PM, Liu L, Hayball JD, Yan K, Rawle DJ, Prow NA, Suhrbier A. Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures. PLoS Pathog 2021;17:e1009215. [PMID: 33439897 DOI: 10.1371/journal.ppat.1009215] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Margolin E, Burgers WA, Sturrock ED, Mendelson M, Chapman R, Douglass N, Williamson AL, Rybicki EP. Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa. Nat Rev Microbiol 2020;18:690-704. [PMID: 32913297 DOI: 10.1038/s41579-020-00441-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
3 Pelin A, Boulton S, Tamming LA, Bell JC, Singaravelu R. Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity. Expert Opin Biol Ther 2020;20:1083-97. [PMID: 32297534 DOI: 10.1080/14712598.2020.1757066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
4 Lorente E, Martín-Galiano AJ, Barnea E, Barriga A, Palomo C, García-Arriaza J, Mir C, Lauzurica P, Esteban M, Admon A, López D. Proteomics Analysis Reveals That Structural Proteins of the Virion Core and Involved in Gene Expression Are the Main Source for HLA Class II Ligands in Vaccinia Virus-Infected Cells. J Proteome Res 2019;18:900-11. [PMID: 30629447 DOI: 10.1021/acs.jproteome.8b00595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Struzik J, Szulc-Dąbrowska L. NF-κB as an Important Factor in Optimizing Poxvirus-Based Vaccines against Viral Infections. Pathogens 2020;9:E1001. [PMID: 33260450 DOI: 10.3390/pathogens9121001] [Reference Citation Analysis]
6 Prow NA, Jimenez Martinez R, Hayball JD, Howley PM, Suhrbier A. Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines. Expert Rev Vaccines 2018;17:925-34. [PMID: 30300041 DOI: 10.1080/14760584.2018.1522255] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
7 Rahman MM, McFadden G. Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways. Vaccines (Basel) 2020;8:E244. [PMID: 32456120 DOI: 10.3390/vaccines8020244] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Fathi A, Addo MM, Dahlke C. Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens. Front Immunol 2020;11:601170. [PMID: 33488596 DOI: 10.3389/fimmu.2020.601170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Afrough B, Dowall S, Hewson R. Emerging viruses and current strategies for vaccine intervention. Clin Exp Immunol 2019;196:157-66. [PMID: 30993690 DOI: 10.1111/cei.13295] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 23.5] [Reference Citation Analysis]
10 Prow NA, Liu L, McCarthy MK, Walters K, Kalkeri R, Geiger J, Koide F, Cooper TH, Eldi P, Nakayama E, Diener KR, Howley PM, Hayball JD, Morrison TE, Suhrbier A. The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates. NPJ Vaccines 2020;5:44. [PMID: 32550013 DOI: 10.1038/s41541-020-0191-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Lorenzo MM, Nogales A, Chiem K, Blasco R, Martínez-Sobrido L. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development. Microbiol Spectr 2022;:e0027222. [PMID: 35583360 DOI: 10.1128/spectrum.00272-22] [Reference Citation Analysis]